Radionuclide imaging for the assessment of myocardial viability in chronic LV dysfunction

Area of Science:

• Cardiology
• Nuclear Medicine
• Medical Imaging

Background:

• Coronary artery disease with depressed left ventricular (LV) function presents critical clinical decision-making challenges.
• Selecting patients for coronary revascularization requires accurate assessment of myocardial viability.

Purpose of the Study:

• To review the role of radionuclide myocardial perfusion imaging in assessing viable myocardium.
• To identify patients with coronary artery disease and LV dysfunction who are most likely to benefit from revascularization.

Main Methods:

• Review of literature on radionuclide myocardial perfusion imaging.
• Analysis of evidence regarding event rates with medical versus revascularization therapy.
• Assessment of noninvasive imaging techniques for determining myocardial viability.

Main Results:

• Patients with viable myocardium have increased event rates with medical treatment compared to revascularization.
• About 40% of patients with coronary artery disease and depressed LV function may improve significantly after revascularization.
• Accurate identification of viable myocardium is key to predicting postoperative improvement in LV function, exercise capacity, and survival.

Conclusions:

• Radionuclide myocardial perfusion imaging is essential for assessing myocardial viability in patients with coronary artery disease and LV dysfunction.
• Identifying patients with viable myocardium optimizes selection for coronary revascularization, improving outcomes.
• Noninvasive imaging aids in identifying patients unlikely to benefit, thus avoiding high surgical risks.